immuno-oncology

Cartoon of businessmen standing around a broken target
Biotech

Arcus halts Gilead-partnered TIGIT trials as it reworks R&D

A key late-stage trial of Arcus Biosciences and Gilead’s anti-TIGIT antibody domvanalimab has flopped.
Ben Adams Dec 12, 2025 10:00am
graphic image of different colored hands shaking

Crescent inks $80M Kelun deal, adding ADC to mix with bispecific

Dec 4, 2025 9:50am
Illustration connected puzzle pieces with the acronym MA

Ipsen inks €1B buyout of French biotech ImCheck

Oct 22, 2025 10:33am
Nobel Prize medal with background of 100 bills

How Nobel-winning cells could become a 'universal drug'

Oct 21, 2025 2:00pm
Gut stomach

Gilead, Arcus keep TIGIT dream alive with 27-month OS data

Oct 13, 2025 7:05am
Graphic of a fork in the road with arrows pointing in either direction
Favicon Fierce Pharma

Editor's Corner—Summit must submit to Big Pharma, stat

Sep 10, 2025 2:50pm